|
1
|
Fortman BJ: Torricelli-Bernoulli sign in
an ulcerating gastric leiomyosarcoma. AJR Am J Roentgenol.
173:199–200. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sureka B, Bansal K and Arora A:
Torricelli-Bernoulli Sign in gastrointestinal stromal tumor. AJR Am
J Roentgenol. 205:W468. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hirota S, Isozaki K, Moriyama Y, Hashimoto
K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M,
et al: Gain-of-function mutations of c-kit in human
gastrointestinal stromal tumors. Science. 279:577–580. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kindblom LG, Remotti HE, Aldenborg F and
Meis-Kindblom JM: Gastrointestinal pacemaker cell tumor (GIPACT):
Gastrointestinal stromal tumors show phenotypic characteristics of
the interstitial cells of Cajal. Am J Pathol. 152:1259–1269.
1998.PubMed/NCBI
|
|
5
|
Miettinen M, Sarlomo-Rikala M and Lasota
J: Gastrointestinal stromal tumors: Recent advances in
understanding of their biology. Hum Pathol. 30:1213–1220. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Graadt van Roggen JF, van Velthuysen MLF
and Hogendoorn PCW: The histopathological differential diagnosis of
gastrointestinal stromal tumours. J Clin Pathol. 54:96–102. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ludwig DJ and Traverso LW: Gut stromal
tumors and their clinical behavior. Am J Surg. 173:390–394. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Connolly EM, Gaffney E and Reynolds JV:
Gastrointestinal stromal tumours. Br J Surg. 90:1178–1186. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumors-definition, clinical, histological,
immunohistochemical, and molecular genetic features and
differential diagnosis. Virchows Arch. 438:1–12. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ueyama T, Guo KJ, Hashimoto H, Daimaru Y
and Enjoji M: A clinicopathologic and immunohistochemical study of
gastrointestinal stromal tumors. Cancer. 69:947–955. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baheti AD, Shinagare AB, O'Neill AC,
Krajewski KM, Hornick JL, George S, Ramaiya NH and Tirumani SH:
MDCT and clinicopathological features of small bowel
gastrointestinal stromal tumours in 102 patients: a single
institute experience. Br J Radiol. 88:201500852015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Efremidou EI, Liratzopoulos N,
Papageorgiou MS, Romanidis K, Manolas KJ and Minopoulos GJ:
Perforated GIST of the small intestine as a rare cause of acute
abdomen: Surgical treatment and adjuvant therapy. Case report. J
Gastrointestin Liver Dis. 15:297–299. 2006.PubMed/NCBI
|
|
13
|
Misawa S, Takeda M, Sakamoto H, Kirii Y,
Ota H and Takagi H: Spontaneous rupture of a giant gastrointestinal
stromal tumor of the jejunum: A case report and literature review.
World J Surg Oncol. 12:1532014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shoji M, Yoshimitsu Y, Maeda T, Sakuma H,
Nakai M and Ueda H: Perforated gastrointestinal stromal tumor
(GIST) in a true jejunal diverticulum in adulthood: Report of a
case. Surg Today. 44:2180–2186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khuri S, Gilshtein H, Darawshy AA, Bahouth
H and Kluger Y: Primary small bowel GIST presenting as a
life-threatening emergency: A report of two cases. Case Rep Surg.
2017:18142542017.PubMed/NCBI
|
|
16
|
Alessiani M, Gianola M, Rossi S, Perfetti
V, Serra P, Zelaschi D, Magnani E and Cobianchi L: Peritonitis
secondary to spontaneous perforation of a primary gastrointestinal
stromal tumour of the small intestine: A case report and a
literature review. Int J Surg Case Rep. 6C:1–62. 2015.PubMed/NCBI
|
|
17
|
Sato K, Tazawa H, Fujisaki S, Fukuhara S,
Imaoka K, Hirata Y, Takahashi M, Fukuda S, Kuga Y, Nishida T, et
al: Acute diffuse peritonitis due to spontaneous rupture of a
primary gastrointestinal stromal tumor of the jejunum: A case
report. Int J Surg Case Rep. 39:288–292. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Driver R: Toricelli's law: An ideal
example of an elementary ODE. Am Math Mon. 105:453–455. 1998.
View Article : Google Scholar
|
|
19
|
Stedman TL: Stedman's Medical Dictionary.
25th Edition. Williams & Wkjins; Baltimore: pp. 1821990
|
|
20
|
Nishida T, Kumano S, Sugiura T, Ikushima
H, Nishikawa K, Ito T and Matsuda H: Multidetector CT of high-risk
patients with occult gastrointestinal stromal tumors. AJR Am J
Roentgenol. 180:185–189. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Amano M, Okuda T, Amano Y, Tajiri T and
Kumazaki T: Magnetic resonance imaging of gastrointestinal stromal
tumor in the abdomen and pelvis. Clin Imaging. 30:127–131. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Grover S, Ashley SW and Raut CP: Small
intestine gastrointestinal stromal tumors. Curr Opin Gastroenterol.
28:113–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
West RB, Corless CL, Chen X, Rubin BP,
Subramanian S, Montgomery K, Zhu S, Ball CA, Nielsen TO, Patel R,
et al: The novel marker, DOG1, is expressed ubiquitously in
gastrointestinal stromal tumors irrespective of KIT or PDGFRA
mutation status. Am J Pathol. 165:107–113. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
DeMatteo RP, Lewis JJ, Leung D, Mudan SS,
Woodruff JM and Brennan MF: Two hundred gastrointestinal stromal
tumors: Recurrence patterns and prognostic factors for survival.
Ann Surg. 231:51–58. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Emory TS, Sobin LH, Lukes L, Lee DH and
O'Leary TJ: Prognosis of gastrointestinal smooth-muscle (stromal)
tumors: Dependence on anatomic site. Am J Surg Pathol. 23:82–87.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Demetri GD, von Mehren M, Antonescu CR,
Dematteo RP, Ganjoo KN, Maki RG, Pisters PWT, Raut CP, Riedel RF,
Schuetze S, Sundar HM, Trent JC and Wayne JD: NCCN Task Force
report: update on the management of patients with gastrointestinal
stromal tumors. J Natl Compr Canc Netw. 8 suppl 2:S1–S41; quiz
S42-S44. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
ESMO/European Sarcoma Network Working
Group, . Gastrointestinal stromal tumors: ESMO Clinical Practice
Guidelines for diagnosis, treatment and follow-up. Ann Oncol.
23:vii49–vii55. 2012.PubMed/NCBI
|
|
28
|
Demetri GD, von Mehren M, Blanke CD, Van
den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA,
Singer S, Janicek M, et al: Efficacy and safety of imatinib
mesylate in advanced gastrointestinal stromal tumors. N Engl J Med.
347:472–480. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Demetri GD, van Oosterom AT, Garrett CR,
Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich
MC, Morgan JA, et al: Efficacy and safety of sunitinib in patients
with advanced gastrointestinal stromal tumour after failure of
imatinib: A randomised controlled trial. Lancet. 368:1329–1338.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wilhelm SM, Dumas J, Adnane L, Lynch M,
Carter CA, Schütz G, Thierauch KH and Zopf D: Regorafenib (BAY
73–4506): A new oral multikinase inhibitor of angiogenic, stromal
and oncogenic receptor tyrosine kinases with potent preclinical
antitumor activity. Int J Cancer. 129:245–255. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kajiura S, Hosokawa A, Nanjyo S, Nakada N,
Ando T and Sugiyama T: A case of a gastrointestinal stromal tumor
of the rectum effectively treated with continuously-administered
regorafenib after failure of imatinib and sunitinib. Nihon
Shokakibyo Gakkai Zasshi. 113:655–661. 2016.(In Japanese).
PubMed/NCBI
|
